Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.63 |
| ▸ | MAPT | P10636 | 6/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.63 |
| ▸ | GAA | P10253 | 3/20 | 0.63 |
| ▸ | THPO | P40225 | 3/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | HPGD | P15428 | 3/20 | 0.63 |
| ▸ | BLM | P54132 | 3/20 | 0.63 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.63 |
| ▸ | APEX1 | P27695 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.63 |
| ▸ | RGS12 | O14924 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.63 |
| ▸ | CA1 | P00915 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA4 | P22748 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8964689 | 0.82 | KDM4E (0.57) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| SCHEMBL9750653 | 0.80 | ALOX15 (0.56) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| SCHEMBL29457181 | 0.80 | ALOX15 (0.56) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| SCHEMBL19199480 | 0.78 | ALOX15 (0.59) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL29382155 | 0.77 | GAA (1.00) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL36348 | 0.77 | GAA (1.00) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL8214147 | 0.76 | GAA (0.96) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL8214151 | 0.76 | GAA (0.96) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| SCHEMBL22982989 | 0.74 | KDM4E (0.72) | KDM4EMAPTHIF1AHSD17B10TDP1 | |
| SCHEMBL10414022 | 0.74 | TRPA1 (0.60) | KDM4EMAPTHIF1AHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012006783-A1 | PROCESS FOR PRODUCTION OF HYDROXYTYROSOL USING ORGANOMETALLIC COMPOUNDS | LONZA LTD (CH) | 2012-01-19 | — | — | WO | claimed |
| CN-103080056-A | Method for preparing hydroxytyrosol by using organic metal compound | LONZA AG | 2013-05-01 | — | — | CN | disclosed |
| WO-2012006783-A1 | PROCESS FOR PRODUCTION OF HYDROXYTYROSOL USING ORGANOMETALLIC COMPOUNDS | LONZA LTD (CH) | 2012-01-19 | — | — | WO | disclosed |
| WO-2012006783-A1 | PROCESS FOR PRODUCTION OF HYDROXYTYROSOL USING ORGANOMETALLIC COMPOUNDS | LONZA LTD (CH) | 2012-01-19 | — | — | WO | disclosed |
| US-20110218158-A1 | DNA CYTOSINE DEAMINASE INHIBITORS | REGENTS OF THE UNIVERSITY OF MINNESOTA | 2011-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110218158-A1 | DNA CYTOSINE DEAMINASE INHIBITORS | DCTD, APOBEC3A, UNG | KDM4E 810/4885MAPT 4260/4885HIF1A 1753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.